Vita 34 AG Stock
Price
Target price
€4.56
€4.56
1.320%
0.06
1.320%
-
19.09.24 / Tradegate
WKN: A0BL84 / Name: Vita 34 / Stock / Healthcare Providers & Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Vita 34 AG Stock
Vita 34 AG gained 1.320% today.
Criterium "Business model" is seen as the biggest plus for Vita 34 AG stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Vita 34 AG in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vita 34 AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vita 34 AG | 1.320% | 1.786% | 3.636% | -4.202% | -12.977% | -71.321% | -62.158% |
| Mediclin AG | -5.980% | -2.542% | -5.738% | -20.139% | -13.534% | -41.327% | -58.182% |
| M1 Kliniken AG | 1.980% | 2.817% | 25.000% | 97.511% | 64.414% | 149.317% | 58.696% |
| Surgery Partners Inc | 2.080% | 8.889% | 13.953% | 3.521% | 2.083% | -24.615% | 323.022% |
News
EQS-News: Vita 34 continues positive trend in the first half of 2024 and once again significantly increases operating cash flow
EQS-News: Vita 34 continues positive trend in the first half of 2024 and once again significantly increases operating cash flow
EQS-Adhoc: Subsidiaries of Vita 34 reach agreement with US licensor
EQS-Adhoc: Subsidiaries of Vita 34 reach agreement with US licensor
EQS-News: Thomas Pfaadt appointed as new Chief Financial Officer of Vita 34 AG
EQS-News: Thomas Pfaadt appointed as new Chief Financial Officer of Vita 34 AG